Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03760042 · ClinicalTrials.gov registry record · Phase 1
Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT03760042 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 32 participants.
The verdict
NCT03760042, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
A double-blind within-subject study to estimate observed application site adverse events following topical applications of crisaborole and vehicle in healthy participants
Interventions
- DRUG Within-Subject Active vs Placebo Topical Applications
- DRUG Within-Subject Active vs. Placebo Topical Applications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2018-11-14 |
| Est. Completion | 2019-04-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03760042
The ClinicalTrials.gov registry entry for NCT03760042 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Within-Subject Active vs Placebo Topical Applications is the first listed.
NCT03760042 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03760042 about?
NCT03760042 is a clinical study titled "Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements". A double-blind within-subject study to estimate observed application site adverse events following topical applications of crisaborole and vehicle in healthy participants
What is the current status of trial NCT03760042?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2018-11-14. Estimated completion is 2019-04-15.
What interventions are being tested in trial NCT03760042?
The interventions under investigation include: Within-Subject Active vs Placebo Topical Applications (DRUG), Within-Subject Active vs. Placebo Topical Applications (DRUG).
Who is sponsoring clinical trial NCT03760042?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.